Inflammatory Disorders - Part A
portes grátis
Inflammatory Disorders - Part A
Donev, Rossen
Elsevier Science Publishing Co Inc
01/2020
348
Dura
Inglês
9780128168448
15 a 20 dias
610
Descrição não disponível.
1. Using evasins to target the chemokine network in inflammation Shoumo Bhattacharya and Akane Kawamura 2. Biological functions and clinical implications of interleukin-34 in inflammatory diseases Yun Ge, Man Huang, Xiao-mei Zhu, and Yong-ming Yao 3. Pattern recognition receptors as potential drug targets in inflammatory disorders Declan P. McKernan 4. Glycosylation changes in inflammatory diseases Sophie Groux-Degroote, Sumeyye Cavdarli, Kenji Uchimura, Fabrice Allain, and Philippe Delannoy 5. Inflammatory bowel disease and targeted oral anti-TNFa therapy Owen R. Griffiths, John Landon, Ruth E. Coxon, Keith Morris, Philip James, and Rachel Adams 6. Interplay between inflammation and cancer Rekha Khandia and Ashok Munjal 7. Microglial NLRP3 inflammasome activation in multiple sclerosis Melis Olcum, Bora Tastan, Cagla Kiser, Sermin Genc and Kursad Genc 8. Sleep deprivation, oxidative stress and inflammation Fatin Atrooz and Samina Salim
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Anti-inflammatory drugs; C-type lectin-like receptors; Cancer; Chemokine; Chemokine-binding proteins; Colony-stimulating factor-1 receptor ligand; Crohn's disease; Cystic fibrosis; Death receptors; Evasin; Experimental autoimmune encephalomyelitis; Gangliosides; Gastrointestinal tract; Glycosaminoglycans; Glycosylation; Host-parasite interactions; Infection; Inflammation; Inflammatory bowel disease; Inflammatory disease; Inflammatory diseases; Interleukin-34; Interleukins; Knottin; Microglia; Monoclonal antibodies; Mucins; Multiple sclerosis; Neurodegenerative disorders; NLRP3 inflammasome; NOD-like receptors; Oral immunotherapy; Oxidative stress; Pattern recognition receptors; Polyclonal antibodies; RIG-like receptors; Signaling pathway; Sleep; Stress; Tick; Toll-like receptors; TRAIL; Tumor associated macrophages (TAMs); Tumor associated neutrophils (TANs); Tumor microenvironment; Tumor necrosis factor-alpha; Ulcerative colitis;
1. Using evasins to target the chemokine network in inflammation Shoumo Bhattacharya and Akane Kawamura 2. Biological functions and clinical implications of interleukin-34 in inflammatory diseases Yun Ge, Man Huang, Xiao-mei Zhu, and Yong-ming Yao 3. Pattern recognition receptors as potential drug targets in inflammatory disorders Declan P. McKernan 4. Glycosylation changes in inflammatory diseases Sophie Groux-Degroote, Sumeyye Cavdarli, Kenji Uchimura, Fabrice Allain, and Philippe Delannoy 5. Inflammatory bowel disease and targeted oral anti-TNFa therapy Owen R. Griffiths, John Landon, Ruth E. Coxon, Keith Morris, Philip James, and Rachel Adams 6. Interplay between inflammation and cancer Rekha Khandia and Ashok Munjal 7. Microglial NLRP3 inflammasome activation in multiple sclerosis Melis Olcum, Bora Tastan, Cagla Kiser, Sermin Genc and Kursad Genc 8. Sleep deprivation, oxidative stress and inflammation Fatin Atrooz and Samina Salim
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Anti-inflammatory drugs; C-type lectin-like receptors; Cancer; Chemokine; Chemokine-binding proteins; Colony-stimulating factor-1 receptor ligand; Crohn's disease; Cystic fibrosis; Death receptors; Evasin; Experimental autoimmune encephalomyelitis; Gangliosides; Gastrointestinal tract; Glycosaminoglycans; Glycosylation; Host-parasite interactions; Infection; Inflammation; Inflammatory bowel disease; Inflammatory disease; Inflammatory diseases; Interleukin-34; Interleukins; Knottin; Microglia; Monoclonal antibodies; Mucins; Multiple sclerosis; Neurodegenerative disorders; NLRP3 inflammasome; NOD-like receptors; Oral immunotherapy; Oxidative stress; Pattern recognition receptors; Polyclonal antibodies; RIG-like receptors; Signaling pathway; Sleep; Stress; Tick; Toll-like receptors; TRAIL; Tumor associated macrophages (TAMs); Tumor associated neutrophils (TANs); Tumor microenvironment; Tumor necrosis factor-alpha; Ulcerative colitis;
